Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Yasutaka Sugamori"'
Autor:
Fatma Rashed, Shingo Kamijyo, Yuri Shimizu, Yuna Hirohashi, Masud Khan, Yasutaka Sugamori, Ramachandran Murali, Kazuhiro Aoki
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Receptor activator of NF-κB ligand (RANKL)-binding peptides inhibit bone resorption and were recently shown to activate bone formation. The stimulatory mechanism underlying bone formation associated with these peptides was explained as RANKL-reverse
Externí odkaz:
https://doaj.org/article/275c273d07f74135b4410f55198e6131
Autor:
Tsuyoshi Sato, Takanori Iwata, Michihiko Usui, Shoichiro Kokabu, Yasutaka Sugamori, Yuki Takaku, Takashi Kobayashi, Ko Ito, Masahito Matsumoto, Shu Takeda, Ren Xu, Dai Chida
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100713- (2020)
Considering that stress condition associated with osteoporosis, the hypothalamic-pituitary-adrenal (HPA) axis, which is essential for central stress response system, is implicated in regulating bone mass accrual. Melanocortin 2 receptor (MC2R), the r
Externí odkaz:
https://doaj.org/article/28877e5ff3ab44c8adb738f553b4e569
Autor:
Yosuke Fukushima, Yumiko Kawata, Takashi Kobayashi, Tsuyoshi Sato, Ko Ito, Yuki Takaku, Yasutaka Sugamori
Publikováno v:
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 34:72-75
A 57-year-old male visited the hospital’s internal medicine department with a chief complaint of cognitive impairment for the past month. His Mini-Mental State Examination (MMSE) score was 23 points, exhibiting mild cognitive impairment. Brain magn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::717d35f1f81a346630aad8632ad4c7f7
https://doi.org/10.1016/j.ajoms.2021.06.006
https://doi.org/10.1016/j.ajoms.2021.06.006
Autor:
Shingo Kamijyo, Yuri Shimizu, Yuna Hirohashi, Kazuhiro Aoki, Fatma Rashed, Ramachandran Murali, Masud Khan, Yasutaka Sugamori
Publikováno v:
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Receptor activator of NF-κB ligand (RANKL)-binding peptides inhibit bone resorption and were recently shown to activate bone formation. The stimulatory mechanism underlying bone formation associated with these peptides was explained as RANKL-reverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7962bcef47bd81f75c8b53b9f5e88e24
http://europepmc.org/articles/PMC8290838
http://europepmc.org/articles/PMC8290838
Autor:
Shu Takeda, Yuki Takaku, Takashi Kobayashi, Dai Chida, Ren Xu, Yasutaka Sugamori, Ko Ito, Shoichiro Kokabu, Michihiko Usui, Tsuyoshi Sato, Masahito Matsumoto, Takanori Iwata
Publikováno v:
Bone Reports
Bone Reports, Vol 13, Iss, Pp 100713-(2020)
Bone Reports, Vol 13, Iss, Pp 100713-(2020)
Considering that stress condition associated with osteoporosis, the hypothalamic-pituitary-adrenal (HPA) axis, which is essential for central stress response system, is implicated in regulating bone mass accrual. Melanocortin 2 receptor (MC2R), the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a491dc47828209761a6ce99f8c263d8
http://europepmc.org/articles/PMC7490991
http://europepmc.org/articles/PMC7490991
Autor:
Masashi Honma, Yasutaka Sugamori, Nobuyuki Udagawa, Kazuhiro Aoki, Yoshiaki Kariya, Genki Kato, Hiroshi Suzuki, Masud Khan, Yasuhiko Tabata, Madoka Hayashi, Shigeki Aoki, Yuki Ikebuchi, Josef M. Penninger
Publikováno v:
Yearbook of Paediatric Endocrinology.
Receptor activator of nuclear factor-kappa B (RANK) ligand (RANKL) binds RANK on the surface of osteoclast precursors to trigger osteoclastogenesis. Recent studies have indicated that osteocytic RANKL has an important role in osteoclastogenesis durin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2e9a2562f21c75d5f4d1b3b89a93c42
https://doi.org/10.1530/ey.16.5.17
https://doi.org/10.1530/ey.16.5.17
Autor:
Kou Matsuo, Masato Okamoto, Yukiyo Tada, Hidefumi Fukushima, Yasutaka Sugamori, Kazuhiro Aoki, Chihiro Nakatomi, Tomoyuki Fujikawa, Akiko Itai, Keiichi Ohya, Osawa Kenji, Eijiro Jimi, Shoichiro Kokabu, Goro Sugiyama, Seiji Watanabe
Publikováno v:
Scopus-Elsevier
Oncotarget
Oncotarget
// Yukiyo Tada 1,2 , Shoichiro Kokabu 1 , Goro Sugiyama 1 , Chihiro Nakatomi 1 , Kazuhiro Aoki 3 , Hidefumi Fukushima 4 , Kenji Osawa 5 , Yasutaka Sugamori 3 , Keiichi Ohya 3 , Masato Okamoto 6 , Tomoyuki Fujikawa 7 , Akiko Itai 7 , Kou Matsuo 8 , Se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79fd337d791ca4c9fc697b708422ea29
https://doi.org/10.18632/oncotarget.2640
https://doi.org/10.18632/oncotarget.2640
Publikováno v:
Studies in health technology and informatics. 245
A New legal structure for rare disease (nambyo) has been established in Japan this year, after 42 years of measures of nambyo. We have been accumulating registry for nambyo from 2003, however, as it was based on paper registration, quality was not en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::072642b7226910b432d9ae67a0af4c66
https://pubmed.ncbi.nlm.nih.gov/29295152
https://pubmed.ncbi.nlm.nih.gov/29295152
Publikováno v:
Journal of Community Medicine & Health Education.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c72c85d1bf47db3995bde09274438fad
https://doi.org/10.4172/2161-0711-c1-030
https://doi.org/10.4172/2161-0711-c1-030
Autor:
Kazuhiro Aoki, Setsuko Mise-Omata, Yasuhiko Tabata, Hiroshi Suzuki, Hisataka Yasuda, Nobuyuki Udagawa, Chizuko Maeda, Masashi Honma, Shigeki Aoki, Ramachandran Murali, Yasutaka Sugamori
Publikováno v:
Bioessays
Both W9 and OP3-4 were known to bind the receptor activator of NF-κB ligand (RANKL), inhibiting osteoclastogenesis. Recently, both peptides were shown to stimulate osteoblast differentiation; however, the mechanism underlying the activity of these p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4a774bc0a1a889c7de28d96a9358f5d
https://pubmed.ncbi.nlm.nih.gov/27345003
https://pubmed.ncbi.nlm.nih.gov/27345003